Redeye states that InfraCom's net sales was below expectations, and InfraCom states a tougher macro-...
Redeye updates its estimates following Arise’s Q1 report yesterday, which presented a solid set of n...
Redeye saw a sales development that was better than our expectations.
Suominen’s earnings recovery continues, although still at a somewhat slower pace than we had previou...
Aspo’s Q1 EBIT was soft relative to estimates, yet markets have now mostly stabilized; all three seg...
Marimekko reports its Q1/24 figures 15th of May. We expect flat sales year-on-year and slightly lowe...
Performance Chemicals grows 17% as EBIT nears breakeven Cost-savings programme successful, but still...
Media still growing ~20% organically despite a 'softer' quarter P&S weighing on revisions, but stron...
The McQuade Center for Strategic Research and Development (MSRD) has signed an exclusive R&D collabo...
Urstark rapport från bolaget… Omsättningen i kvartalet uppgick till EUR 28m, vilket motsvarar en til...
Recorded sales improved to SEK 17.9m (10.9m in Q4 and SEK 0m in Q1 2023), and the cash balance was ...
Relais reported Q1 adjusted EBITA of EUR 9.7m, 13% above LSEG Data & Analytics consensus.
New dev collaboration with MSRD on IRL757 Seeking for a partner for mesdopetam's Ph 3 Webcast today ...
Investors House reported Q1 revenues of EUR 1.6m, 4% below our 1.
MODI reported sales growth in Q1’24 of 31%, confirming that the strong momentum seen in H2’23 carrie...
Fortsatt god tillväxt och lönsamhet Efter ett rekordstarkt 2023 med en tillväxt på 134% inledde Mave...
Redeye gives an initial take on the news that IRLAB has entered into a development cooperation with ...
Redeye comments on G5’s Q1-results where topline was softer than expected while solid profitability,...
Sales-2% and adj. EBITA +11% vs. ABGSCe Stunning 9.